BioTek Instruments

BioTek Instruments designs and manufactures laboratory instruments—including microplate readers/washers/dispenser systems and advanced cell imaging platforms—that enable high-throughput analysis of biomolecules/cells/tissues across the life sciences sector. Founded in Vermont in the late '60s as a family business focused on medical device calibration/testing equipment, it pivoted to become an industry leader supporting pharmaceutical R&D/life science labs worldwide with innovative analytical devices. Acquired by Agilent Technologies for $1.165B USD in August 2019, BioTek continues as an active brand/subsidiary within the larger organization’s workflow solutions portfolio. The company has no drug development pipeline or clinical-stage assets—it serves as an enabling technology provider rather than a biotech/pharma developer.